Zoetis Inc. (ZTS) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Parsippany, NJ, 미국. 현재 CEO는 Kristin C. Peck.
ZTS 을(를) 보유 IPO 날짜 2013-02-01, 13,800 명의 정규직 직원, 에 상장 NYSE, 시가총액 $51.12B.
Zoetis Inc. is a global animal health company that discovers, develops, manufactures, and commercializes medicines, vaccines, and diagnostic products for livestock and companion animals. The company serves cattle, swine, poultry, fish, sheep, dogs, cats, and horses through a comprehensive portfolio including vaccines, anti-infectives, parasiticides, pain management products, dermatology treatments, and medicated feed additives. Additionally, Zoetis provides diagnostic solutions such as point-of-care blood and urine analysis, rapid immunoassay tests, and reference laboratory services, along with nutritional and precision animal health products. The company distributes its products through veterinarians, livestock producers, retail outlets, and third-party veterinary distributors. Founded in 1952 and headquartered in Parsippany, New Jersey, Zoetis operates internationally to serve the global animal health market.
